| SciPort RLP

2015 - 2016

Ganfort (201450): A phase IV study on the changes in ocular signs and symptoms in patients with ocular hypertension or open-angle glaucoma switched from Ganfort® eye drops (bimatoprost 0.03%/timolol 0.5%) to Taptiqom® eye drops (tafluprost 0.0015%/timolol 0.5%).

PD Dr. Katrin

2015 - 2020

The significance of amygdalin in the therapy of renal cell carcinoma

PD Dr. Eva

2015 - 2016

IRISS: AN OPEN LABEL, REGISTRY STUDY OF THE SAFETY OF ILUVIEN® 190 MICROGRAMS INTRAVITREAL IMPLANT IN APPLICATOR

Prof. Dr. Norbert

2015 - 2017

Lebensqualität von Patienten mit Leberzirrhose und Hepatischer Enzephalopathie unter einer routineärztlichen Behandlung mit L-Ornithin-L-Aspartat über 12 Wochen

Dr. Marc

2015 - 2017

Actovegin and Traumeel Affects Biological Function of Primary Human Skeletal Muscle Cells – an in vitro study

Dr. Stefan,
Dr. Ulrike,
Prof. Dr. Philipp

2015 - 2017

CyPass TMI-13-01: RANDOMIZED PROSPECTIVE CLINICAL EVALUATION OF THE SAFETY AND EFFECTIVENESS OF VISCO-ASSISTED CYPASS IMPLANTATION IN PATIENTS WITH OPEN ANGLE GLAUCOMA

Prof. Dr. Norbert

2015 - 2017

AQUA 17850: Open-label Phase-4 study to examine the change of vision-related quality of life in subjects with diabetic macular edema (DME) during treatment with intravitreal injections of 2 mg aflibercept according to EU label for the first year of treatment

Dr. Katharina,
PD Dr. Katrin

2015 - 2017

"Mechanismen der fibrosehemmenden Wirkung von Linagliptin in einem renalen Fibrosemodell"

Univ.-Prof. Dr. Jens

2015 - 2020

Registry: Transanal Total Mesorectal Excision

Prof. Dr. Werner

2015 - 2017

Synteract HCR: ISTH0036 in trabeculectomy

PD Dr. Katrin

FB 04 - Universitätsmedizin

Johannes Gutenberg-Universität Mainz

Starten Sie Ihre Suche...

FB 04 - Universitätsmedizin

Johannes Gutenberg-Universität Mainz